They show that unsuccessful HCV treatment was more common among people with a CD4+ cell count less than 350, among both people with and without cirrhosis, and suggest that a low CD4+ cell could likely play a role in unsuccessful HCV treatment. The gene discussed is CD4; the disease is Cirrhosis.